Canada on Thursday authorized Moderna Inc's bivalent COVID-19 shots for adults, adding the first Omicron-adapted vaccine to its arsenal just as falling temperatures are poised to force people indoors where the risk of infection is higher.
Canada on Thursday authorized Moderna Inc's bivalent COVID-19 shots for adults, adding the first Omicron-adapted vaccine to its arsenal just as falling temperatures are poised to force people indoors where the risk of infection is higher.
Serum Institute of India's owner and CEO Adar Poonawalla on Thursday said the company stopped production of the Covishield vaccine in December last year and some 100 million doses it had in stock at the time were dumped upon expiry.
India News: PUNE: Serum Institute of India's owner and CEO Adar Poonawalla on Thursday said the company stopped production of the Covishield vaccine in December l.
Covishield takes the lion's share of its after-effects on the jabbed population, as per the RTI reply. - Articles from The Weather Channel | weather.com
According to Dr Aseem Malhotra, the vaccine manufactured in India by the Serum Institute is ‘even worse’ than mRNA COVID-19 vaccines when it came to concerns such as heart attacks and strokes.
Serum Institute of India (SII) CEO Adar Poonawalla on April 12 said it has restarted manufacturing of COVID-19 vaccine Covishield amid rising numbers of cases of the virus infection.
Older Americans and those with weakened immune systems, groups still particularly vulnerable to the virus, may receive additional shots of the reformulated vaccine, federal officials said.